Should the patent system for new medicines be abolished?
Publication
, Journal Article
DiMasi, JA; Grabowski, HG
Published in: Clinical pharmacology and therapeutics
November 2007
Duke Scholars
Published In
Clinical pharmacology and therapeutics
DOI
EISSN
1532-6535
ISSN
0009-9236
Publication Date
November 2007
Volume
82
Issue
5
Start / End Page
488 / 490
Related Subject Headings
- United States
- Public Policy
- Pharmacology & Pharmacy
- Pharmaceutical Preparations
- Patents as Topic
- Orphan Drug Production
- Legislation, Drug
- Insurance Coverage
- Humans
- Financing, Government
Citation
APA
Chicago
ICMJE
MLA
NLM
DiMasi, J. A., & Grabowski, H. G. (2007). Should the patent system for new medicines be abolished? Clinical Pharmacology and Therapeutics, 82(5), 488–490. https://doi.org/10.1038/sj.clpt.6100393
DiMasi, J. A., and H. G. Grabowski. “Should the patent system for new medicines be abolished?” Clinical Pharmacology and Therapeutics 82, no. 5 (November 2007): 488–90. https://doi.org/10.1038/sj.clpt.6100393.
DiMasi JA, Grabowski HG. Should the patent system for new medicines be abolished? Clinical pharmacology and therapeutics. 2007 Nov;82(5):488–90.
DiMasi, J. A., and H. G. Grabowski. “Should the patent system for new medicines be abolished?” Clinical Pharmacology and Therapeutics, vol. 82, no. 5, Nov. 2007, pp. 488–90. Epmc, doi:10.1038/sj.clpt.6100393.
DiMasi JA, Grabowski HG. Should the patent system for new medicines be abolished? Clinical pharmacology and therapeutics. 2007 Nov;82(5):488–490.
Published In
Clinical pharmacology and therapeutics
DOI
EISSN
1532-6535
ISSN
0009-9236
Publication Date
November 2007
Volume
82
Issue
5
Start / End Page
488 / 490
Related Subject Headings
- United States
- Public Policy
- Pharmacology & Pharmacy
- Pharmaceutical Preparations
- Patents as Topic
- Orphan Drug Production
- Legislation, Drug
- Insurance Coverage
- Humans
- Financing, Government